For the Inventor, By the Inventor

Enter assignee name

Stockholm, Sweden

Bioarctic Neuroscience Ab

USPTO Granted Patents = 16

% Expired Patents = 25.0

CIPO Patents = 2

EPO Patents = 3

Forward Citations = 160

Loading Chart...

Loading Chart...

22 inventors (with patents filed for the assignee):

Lars Lannfelt (14 out of 17 patents)

Pär Gellerfors (8 out of 10 patents)

Alex Kasrayan (4 out of 4 patents)

4. Eva Nordström (4 out of 4 patents)

5. Monica Ekberg (4 out of 4 patents)

6. Valentina Screpanti Sundquist (4 out of 4 patents)

7. Mats Holmquist (4 out of 4 patents)

8. Joakim Bergström (2 out of 2 patents)

9. Martin Ingelsson (2 out of 2 patents)

10. Dag Sehlin (2 out of 3 patents)

11. Frida Ekholm Pettersson (2 out of 2 patents)

12. Hillevi Englund (2 out of 2 patents)

13. Camilla Nilsberth (2 out of 3 patents)

14. Anita Campbell (2 out of 2 patents)

15. Jan Näslund (2 out of 3 patents)

16 patents: Sort by Forward Citations

1. 9895234 - Spinal cord devices and methods for promoting axonal regeneration (2018-02-20),

2. 9573994 - Aβ protofibril binding antibodies (2017-02-21),

3. 9315569 - Antibodies and vaccines for use in therapeutic and diagnostic methods for α-synuclein-related disorders (2016-04-19),

4. 9084832 - Protofibril-binding antibodies and their use in therapeutic and diagnostic methods for parkinson's disease, dementia with lewy bodies and other α-synucleinopathies (2015-07-21),

5. 9034334 - Protofibril selective antibodies and the use thereof (2015-05-19),

6. 8999936 - Antibodies specific for soluble amyloid beta peptide protofibrils and uses thereof (2015-04-07),

7. 8968734 - Protofibril-binding antibodies and their use in therapeutic and diagnostic methods for Parkinson's disease, dementia with lewy bodies and other α-synucleinopathies (2015-03-03),

8. 8859501 - Protofibril-binding antibodies and their use in thereapeutic and diagnostic methods for parkinson's disease, dementia with lewy bodies and other alpha-synucleinopathies (2014-10-14),

9. 8809506 - Antibodies and vaccines for use in therapeutic and diagnostic methods for α-synuclein-related disorders (2014-08-19),

10. 8632776 - Protofibril-binding antibodies and their use in therapeutic and diagnostic methods for Parkinson's disease, dementia with lewy bodies and other α-synucleinopathies (2014-01-21),

11. 8409575 - Antibodies specific for amyloid beta protofibril (2013-04-02),

12. 8404459 - Antibodies specific for soluble amyloid beta peptide protofibrils and uses thereof (2013-03-26),

13. 8106164 - Antibodies specific for soluble amyloid beta peptide protofibrils and uses thereof (2012-01-31),

14. 8025878 - Protofibril selective antibodies and the use thereof (2011-09-27),

15. 7709695 - Transgenic mouse expressing arctic mutation E693G (2010-05-04),

Company Overview

Bioarctic Neuroscience Ab is a biotechnology company based in Stockholm, Sweden, specializing in the development of innovative treatments for neurodegenerative diseases. The company focuses on advancing therapies targeting Alzheimer's disease and other related conditions through its proprietary research and technology platforms. By leveraging its expertise in protein science and drug development, Bioarctic aims to address significant unmet medical needs in the field of neuroscience, contributing to improved patient outcomes.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

16 Patents

#53 in Stockholm

#407 in Sweden

#37,868 in the World

Stockholm, Sweden

Bioarctic Neuroscience Ab

Forward Citations = 160

22 inventors:

Lars Lannfelt (14 out of 17 patents)

Pär Gellerfors (8 out of 10 patents)

Alex Kasrayan (4 out of 4 patents)

4. Eva Nordström (4 out of 4 patents)

5. Monica Ekberg (4 out of 4 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Bioarctic Neuroscience Ab. Retrieved from https://idiyas.com/company/bioarctic-neuroscience-ab

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…